Stevioside Inhibits Experimental Fibrosis by Downregulating Profibrotic Smad Pathways and Blocking HSC Activation.

Authors

Sael Casas-Grajales
Diana Alvarez-Suarez
Erika Ramos-Tovar
Laura Dayana Buendía-Montaño
Karina Reyes-Gordillo, George Washington University
Javier Camacho
Víctor Tsutsumi
M Raj Lakshman, George Washington University
Pablo Muriel

Document Type

Journal Article

Publication Date

12-18-2018

Journal

Basic & clinical pharmacology & toxicology

DOI

10.1111/bcpt.13194

Comments

Epub ahead of print

APA Citation

Casas-Grajales, S., Alvarez-Suarez, D., Ramos-Tovar, E., Buendía-Montaño, L., Reyes-Gordillo, K., Camacho, J., Tsutsumi, V., Raj Lakshman, M., & Muriel, P. (2018). Stevioside Inhibits Experimental Fibrosis by Downregulating Profibrotic Smad Pathways and Blocking HSC Activation.. Basic & clinical pharmacology & toxicology, (). http://dx.doi.org/10.1111/bcpt.13194

Peer Reviewed

1